Inscripta’s Acquisition of Infinome Biosciences and Sestina Bio

Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio.  These acquisitions advance Inscripta’s…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now